Nicholas Glover Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nicholas Glover.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nicholas Glover. Nicholas Glover is Director in MEI Pharma, Inc. ($MEIP) and CEO and President in ProNAi Therapeutics Inc ($DNAI).
Latest Insider Trading Transactions of Nicholas Glover
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 07 2020 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 | |
| Jul 03 2019 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 2.52 | 40,000 | 100,800 | 40,000 | |
| Mar 05 2019 | SRRA | Sierra Oncology, I ... | Glover Nicholas | CEO and President | Option Exercise | A | 1.96 | 607,500 | 1,190,700 | 607,500 | |
| Jul 16 2018 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 4.28 | 40,000 | 171,200 | 40,000 | |
| Mar 07 2018 | SRRA | Sierra Oncology, I ... | Glover Nicholas | CEO and President | Option Exercise | A | 2.36 | 562,780 | 1,328,161 | 562,780 | |
| Jul 10 2017 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 2.83 | 40,000 | 113,200 | 118,793 | |
| Mar 08 2017 | SRRA | Sierra Oncology, I ... | Glover Nicholas | CEO and President | Option Exercise | A | 1.45 | 195,000 | 282,750 | 195,000 | |
| Oct 04 2016 | DNAI | ProNAi Therapeutic ... | Glover Nicholas | CEO and President | Option Exercise | A | 1.82 | 500,000 | 910,000 | 500,000 | |
| Aug 01 2016 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 1.36 | 40,000 | 54,400 | 78,793 | |
| Mar 10 2016 | DNAI | ProNAi Therapeutic ... | Glover Nicholas | CEO and President | Option Exercise | A | 6.58 | 161,250 | 1,061,025 | 161,250 | |
| Jan 19 2016 | DNAI | ProNAi Therapeutic ... | Glover Nicholas | CEO and President | Option Exercise | M | 0.97 | 5,000 | 4,845 | 864,219 | |
| Jan 19 2016 | DNAI | ProNAi Therapeutic ... | Glover Nicholas | CEO and President | Sell | S | 10.04 | 5,000 | 50,223 | 0 | 5 K to 0 (-100.00 %) |
| Jan 19 2016 | DNAI | ProNAi Therapeutic ... | Glover Nicholas | CEO and President | Buy | M | 0.97 | 5,000 | 4,845 | 5,000 | 0 to 5 K |
| Jul 29 2015 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 1.57 | 20,000 | 31,400 | 38,793 | |
| Jun 11 2013 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 8.09 | 4,063 | 32,870 | 4,063 |
Page: 1